BioCentury
ARTICLE | Clinical News

Cimzia certolizumab pegol: Phase III data

February 20, 2012 8:00 AM UTC

Top-line data from the double-blind, international Phase III RAPID-PsA trial in 409 patients with adult-onset active and progressive psoriatic arthritis showed that Cimzia significantly improved signs...